Author Archives - c.schmidt@augmenticon.ch

Augmenticon Receives ISO 9001 Certification

Zurich, Switzerland – AUGMENTICON AG, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools, announces the certification of its quality management system by TUV Rheinland according to the ISO 9001:2015 standard. Augmenticon’s decision to work towards the ISO 9001:2015 standard was driven by more than 20 years of experience with pharmaceutical quality management systems and a…

Sofie Inc. enters into partnership with Augmenticon

Sofie Inc. enters into partnership with AUGMENTICONTM to access AR/MR technology to enhance radiopharmaceutical manufacturing reliability across its US based radiopharmacy network. Zurich, Switzerland – AUGMENTICONTM, a privately held technology company developing Augmented-/Mixed-Reality (AR-/MR)-tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the formation of a strategic, non-exclusive development partnership with Sofie Inc. Sofie will use…

InnoSuisse and Augmenticon fund AR-/MR-Technology Project

AUGMENTICON™ enters into a collaboration with the Center for Radiopharmaceutical Sciences, D-CHAB at ETH-Zurich and the Institute of Interactive Technologies at FHNW-Windisch to develop AR & mixed reality tools to extend AUGMENTICON`s SHARE and ASSYST platform technology. The project is jointly funded by the Swiss Innovation Agency, Innosuisse, and AUGMENTICON™. Zurich, Switzerland – AUGMENTICON™ a…

Friedrich Gause joins AUGMENTICON

Friedrich Gause joins AUGMENTICON as Senior Vice President Finance & Strategy Development Zurich, Switzerland – AUGMENTICONTM, a privately held Augmented-/Mixed-Reality (AR/MR-)Technology company, developing novel tools for a cost-effective, high-quality manufacturing of (radio-)pharmaceuticals, announces the appointment of Friedrich Gause as its Senior Vice President Finance and Strategy Development. Mr. Gause will take care of developing AUGMENTICON’s corporate…